2'-Fluoro-2'-deoxythymidine (often abbreviated as FdU or FdThd) is a nucleoside analog of thymidine, characterized by the substitution of a fluorine atom at the 2' position of the deoxyribose sugar. This modification enhances its stability and alters its biological activity, making it a subject of interest in antiviral and anticancer research. The compound exhibits properties similar to thymidine, allowing it to be incorporated into DNA during replication, but the presence of the fluorine atom can disrupt normal DNA function, leading to cytotoxic effects in rapidly dividing cells. 2'-Fluoro-2'-deoxythymidine is known for its potential use in treating viral infections, particularly HIV, and certain types of cancer, as it can inhibit DNA synthesis. Its chemical structure includes a pyrimidine base (thymine) linked to a deoxyribose sugar, and it is typically administered in a phosphorylated form to enhance its bioavailability and efficacy. As with many nucleoside analogs, careful consideration of its pharmacokinetics and potential side effects is essential in therapeutic applications.

2'-Fluoro-2'-deoxythymidine

2923-73-1: 2'-Fluoro-2'-deoxythymidine (often abbreviated as FdU or FdThd) is a nucleoside analog of thymidine, characterized by the substitution of a fluorine atom at the 2' position of the deoxyribose sugar. This modification enhances its stability and alters its biological activity, making it a subject of interest in antiviral and anticancer research. The compound exhibits properties similar to thymidine, allowing it to be incorporated into DNA during replication, but the presence of the fluorine atom can disrupt normal DNA function, leading to cytotoxic effects in rapidly dividing cells. 2'-Fluoro-2'-deoxythymidine is known for its potential use in treating viral infections, particularly HIV, and certain types of cancer, as it can inhibit DNA synthesis. Its chemical structure includes a pyrimidine base (thymine) linked to a deoxyribose sugar, and it is typically administered in a phosphorylated form to enhance its bioavailability and efficacy. As with many nucleoside analogs, careful consideration of its pharmacokinetics and potential side effects is essential in therapeutic applications.

CAS 2923-73-1

2'-Fluoro-2'-deoxythymidine

2''-Deoxy-2''-fluoro-5-methyluridine

Ref: 7W-GN7076